NCT04632160View on ClinicalTrials.gov

Extended IASD Investigation: REDUCE LAP-HF IV

NAWithdrawnINTERVENTIONAL
0
Timeline

Start Date

December 1, 2021

Primary Completion Date

January 1, 2022

Study Completion Date

January 1, 2027

Conditions
Heart Failure With Preserved Ejection FractionHeart Failure With Mid Range Ejection Fraction
Interventions
DEVICE

IASD System II

The implant is placed across the interatrial septum using a percutaneous transcatheter approach.

Sponsors

Lead Sponsor

Corvia Medical
All Listed Sponsors
lead

Corvia Medical

INDUSTRY

NCT04632160 - Extended IASD Investigation: REDUCE LAP-HF IV | Biotech Hunter | Biotech Hunter